Denmark-based Novo Holdings has carved a niche as a specialist LP and direct investor in life sciences opportunities. Sofia Karadima catches up with senior director Samir Kamal

Established in 1999, Novo Holdings is a Denmark-based investment firm, interested in private equity investments that focus on healthcare. It is the holding company of the Novo Group, including Novo Nordisk and Novozymes, and is fully owned by the Novo Nordisk Foundation.

More from this company

Related Content

Search by Category